Preimplantation Genetic Testing – (PGT-A)

Preimplantation Genetic Testing – (PGT-A) is a form of genetic testing that is performed on embryos created through in vitro fertilization (IVF) before they are implanted into the uterus. The purpose of PGT-A is to determine if an embryo has a normal number of chromosomes, which is important for ensuring a successful pregnancy and healthy baby.

In the PGT-A process, a small number of cells are removed from an embryo a few days after it has been created through IVF. These cells are then analyzed in a laboratory to determine if they contain the correct number of chromosomes. If an embryo is found to have an abnormal number of chromosomes, it is likely to result in a failed pregnancy or a child with a genetic disorder such as Down syndrome.

PGT-A can be performed on embryos that are at the blastocyst stage, which is around five days after fertilization, or at the eight-cell stage, which is around three days after fertilization.

The benefits of PGT-A include an increased chance of a successful pregnancy and healthy baby, as well as the ability to reduce the risk of a miscarriage or the need for additional medical treatments.

In conclusion, Preimplantation Genetic Testing – (PGT-A) is a valuable tool for couples undergoing in vitro fertilization (IVF) who wish to ensure the health of their future child. By analyzing embryos for normal chromosome numbers, PGT-A can help to increase the chances of a successful pregnancy and healthy baby, as well as reduce the risk of genetic disorders.